Bonnie H. Anderson
Bonnie H. Anderson is Chairman and Chief Executive Officer of Veracyte, a leading genomic diagnostics company that improves the lives of patients by providing answers to challenging clinical questions. The company’s genomic tests help patients avoid invasive surgeries and other costly procedures, while enabling improved treatment options. Ms. Anderson’s career spans over 30 years in regulated diagnostics and life science markets. She cofounded Veracyte in 2008 and served as the company’s President and Chief Executive Officer until 2016, when she was also appointed Chairman of the Board. She took the company public in 2013 and spearheaded commercialization of Veracyte’s first three market-leading products.
Prior to Veracyte, Ms. Anderson provided strategic consulting services to venture capital firms and early-stage businesses following 18 years in leadership positions at Beckman Coulter. She serves on the board of Castle Biosciences and on the steering committee for the Coalition for 21st Century Medicine and is a trustee emeritus of the Keck Graduate Institute of Applied Life Sciences. She graduated from Indiana University of Pennsylvania with a Bachelor of Science degree in Medical Technology and in 2012 was honored with a “Distinguished Alumni” award. Ms. Anderson has received numerous awards for her industry leadership, including: the Wallace H. Coulter Award for Healthcare Innovation (2017); “Fiercest Women in Life Sciences” (FiercePharma 2017); “100 Most Creative People in Business” (Fast Company, 2015); “Most Influential Women in Bay Area Business” and “Bay Area’s Most Admired CEOs” ( San Francisco Business Times, 2013 and 2014); and “Women of Influence” (Silicon Valley Business Journal, 2013).